Expanded leadership team as eXoZymes ramps up commercial growth Damien Perriman brings more than two decades of experience in ...

PM Eastern Monrovia, CA, April 02, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of ...

A study published in Science Advances has revealed promising strategies to significantly improve crop yields by addressing ...

PM Eastern Monrovia, CA, April 02, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that ...

After some high-profile crashes, the one-time biotech darling is inching toward success with its Hunter syndrome treatment, ...

Forestry waste can be turned into a high-value fatty acid, thanks to a bright red yeast engineered by University of Alberta ...

An optogenetic method for controlling the movement of starfish oocytes has been developed, which could have applications for ...

Researchers engineered Shewanella oneidensis to produce extracellular DNA hydrogels, enabling the development of biohybrid materials for use in energy, biotechnology, and regenerative systems.

A groundbreaking study published in Science Advances has revealed promising strategies to significantly improve crop yields by addressing ...

This development comes at a time when pharmaceutical firms are discontinuing discovery efforts in next-generation COVID-19 treatments.

Denali Therapeutics, Inc. (NASDAQ:DNLI) shares traded higher on Wednesday after the company initiated its biologics license application (BLA) for the accelerated approval of Tividenofusp Alfa for the ...